Global Bioceramics Market is accounted for $12.95 billion in 2015 and is expected to reach $20.05 billion by 2022 growing at a CAGR of 6.4% during the forecast period. Increasing demand for medical services and surgical intervention, rising treatment in dental care and growing consumer incomes are some of the key factors driving the market growth. North America’s bioceramics market is anticipated to grow strong owing to research in bioceramics, increase in cancer occurrence rate, rising incidence of cardiovascular diseases in the U.S and escalating funding and R&D activities in Canada. Europe is the largest market for bioceramics owing to its optimistic outlook towards the orthopaedic sector, primarily in Germany.
Request a sample copy of Report @http://www.orbisresearch.com/contacts/request-sample/184638
Some of the key players in the market include Stryker Corporation, Covalon Technologies Ltd, Carpenter Technology Corp, Morgan Advanced Materials, CoorsTek Medical LLC, Amedica Corp, Zimmer Biomet Holdings, Inc., Invibio Ltd., Wright Medical Technology, Inc., Corbion N.V., Berkeley Advanced Biomaterials, Inc, Evonik Industries AG, Bayer AG, Ceramics GmbH, Royal DSM, DENTSPLY International, Inc., Collagen Matrix, Inc., Smith & Nephew plc, Kyocera Corp., Tosoh Corp and Nobel Biocare.
Drug Delivery Systems
Browse Full Report with TOC@ http://www.orbisresearch.com/reports/index/bioceramics-global-market-outlook-2015-2022
Product Type Covered:
Rest of Europe
Rest of Asia Pacific
Rest of the World
Enquiry Before buying Report@http://www.orbisresearch.com/contacts/enquiry-before-buying/184638